← SynDRA
MIZOLASTINE
SynDRA canonical compound SYN0003760 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | HRH1 |
|---|
| Mechanism of action | Histamine receptor antagonist |
|---|
| Indication | allergic rhinitis | urticaria |
|---|
| Disease area | allergy |
|---|
All known targets
Mechanisms of action (all sources)
- Histamine receptor antagonist
- HRH1 ANTAGONIST
- Histamine H1 receptor antagonist
Drug classes
- Histamine Agents
- Histamine Antagonists
- Histamine H1 Antagonists
- Histamine H1 Antagonists, Non-Sedating
- Neurotransmitter Agents
ATC classes
- R06A · ANTIHISTAMINES FOR SYSTEMIC USE
Cross-references
Synonyms
- SL 85.0324
- mistamine
- mizollen
- zolistan
- Mizolastina
- Mizollen
- Mistalin
- Mistamine
- Mizolastinum
- Mizolen
- Zolim
- Zolistam
- Zolistan
- Allphar brand of mizolastine
- Galderma brand of mizolastine
- Mizolastine [INN]
- Novag brand of mizolastine
- Sanofi Synthelabo brand of mizolastine
- Schwarz brand of mizolastine
- MKC-431
- Mizolastina [INN-Spanish]
- Mizolastinum [INN-Latin]
- Mizollen (TN)
- SL-85.0324
- Mizolastine (JAN/INN)
- 2-((1-(1-(p-Fluorobenzyl)-2-benzimidazolyl)-4-piperidyl)methylamino)-4(3H)-pyrimidinone
- 2-[[1-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]piperidin-4-yl]-methylamino]-1H-pyrimidin-6-one
- DTXCID3026801
- RefChem:819015
- R06AX25
- C24H25FN6O
- Mizolastine (Mizollen)
- NCGC00181013-01
- CAS-108612-45-9
- Mizolastine [INN:BAN]
- UNII-244O1F90NA
- CCRIS 8410
- MFCD23140913
Look up MIZOLASTINE in the interactive SynDRA portal →